ALPHACREST CAPITAL MANAGEMENT LLC – Neurocrine Biosciences, Inc. Transaction History
ALPHACREST CAPITAL MANAGEMENT LLC portfolio value:
$3.03M
portfolio value
ALPHACREST CAPITAL MANAGEMENT LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.07% | 851 shares | 332K | $106.21 | 28.55K |
| Q2 2022 | share | Increase | +59.22% | 10.30K shares | 1.07M | $97.48 | 27.70K |
| Q1 2022 | share | Decrease | -45.39% | -14.46K shares | -1.08M | $93.75 | 17.4K |
| Q4 2021 | share | Increase | +130.11% | 18.01K shares | 1.38M | $84.63 | 31.86K |
| Q3 2021 | share | Decrease | -44.14% | -10.94K shares | -1.08M | $95.91 | 13.84K |
| Q2 2021 | share | Increase | +114.88% | 13.25K shares | 1.29M | $97.32 | 24.78K |
| Q1 2021 | share | Increase | +3.99% | 443 shares | 59K | $97.25 | 11.53K |
| Q4 2020 | share | Increase | +22.04% | 2.00K shares | 189K | $95.85 | 11.09K |
| Q3 2020 | share | Increase | +382.23% | 7.20K shares | 644K | $96.16 | 9.09K |
| Q2 2020 | share | Decrease | -85.16% | -10.81K shares | -869K | $122 | 1.88K |
| Q1 2020 | share | Decrease | -2.87% | -375 shares | -306K | $86.55 | 12.69K |
| Q4 2019 | share | Decrease | -2.95% | -398 shares | 191K | $107.49 | 13.07K |
| Q3 2019 | share | Increase | +1.74% | 231 shares | 96K | $90.11 | 13.47K |
| Q2 2019 | share | Increase | +156.89% | 8.08K shares | 664K | $84.43 | 13.24K |
| Q1 2019 | share | Increase | 0.00% | 5.15K shares | 454K | $88.1 | 5.15K |